Editorial for "Potential Anti-Human Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer"

被引：0
|
作者：
Geitung, Jonn Terje [1 ,2 ]
机构：
[1] Univ Oslo, Oslo, Norway
[2] Akershus Univ Hosp, Oslo, Norway
来源：
JOURNAL OF MAGNETIC RESONANCE IMAGING | 2023年 / 58卷 / 05期
关键词：
D O I：
10.1002/jmri.28626
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1615 / 1616
页数：2
相关论文
共 50 条
  • [31] The clinical benefit of epidermal growth factor receptor and human epidermal growth factor receptor 2 targeted agents adding to endocrine therapy in hormone receptor-positive breast cancer
    Li, Huan
    Zhai, Qing
    Yu, Bo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S218 - S223
  • [32] Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancer
    Zardavas, Dimitrios
    Bozovic-Spasojevic, Ivana
    De Azambuja, Evandro
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) : 612 - 622
  • [33] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Human epidermal growth factor receptor 2-targeted therapies in breast cancer
    Nahta, Rita
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 949 - 952
  • [35] The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
    Wang, Jane
    Shih, Tiffany Ting-Fang
    Yen, Ruoh-Fang
    Lu, Yen-Shen
    Chen, Chin-Yu
    Mao, Tsui-Lien
    Lin, Ching-Hung
    Kuo, Wen-Hung
    Tsai, Yuh-Show
    Chang, King-Jen
    Chien, Kuo-Liong
    ACADEMIC RADIOLOGY, 2011, 18 (02) : 212 - 219
  • [36] The Association of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 with Prognosis of Colorectal Cancer under FOLFOX Chemotherapy
    Qian, H.
    Huang, Wenzhi
    Zhang, Y.
    Cheng, Xiaofei
    Zhong, C.
    Tian, F.
    Chu, Ziang
    Zhou, T.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 25 - 30
  • [37] Progesterone receptor and human epidermal growth factor receptor 2 status: An independent influence on the efficacy of endocrine therapy in breast cancer? Reply
    Dowsett, M
    Cuzick, J
    Wale, C
    Howell, T
    Houghton, J
    Baum, M
    Buzdar, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1482 - 1482
  • [38] Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer
    Almhanna, Khaldoun
    Meredith, Kenneth L.
    Hoffe, Sarah E.
    Shridhar, Ravi
    Coppola, Domenico
    CANCER CONTROL, 2013, 20 (02) : 111 - 116
  • [39] A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer
    Yexing Li
    Zixuan Cheng
    Olivier Gevaert
    Lan He
    Yanqi Huang
    Xin Chen
    Xiaomei Huang
    Xiaomei Wu
    Wen Zhang
    Mengyi Dong
    Jia Huang
    Yucun Huang
    Ting Xia
    Changhong Liang
    Zaiyi Liu
    ChineseJournalofCancerResearch, 2020, 32 (01) : 62 - 71
  • [40] A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer
    Li, Yexing
    Cheng, Zixuan
    Gevaert, Olivier
    He, Lan
    Huang, Yanqi
    Chen, Xin
    Huang, Xiaomei
    Wu, Xiaomei
    Zhang, Wen
    Dong, Mengyi
    Huang, Jia
    Huang, Yucun
    Xia, Ting
    Liang, Changhong
    Liu, Zaiyi
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (01) : 62 - +
12345